Integramed America, Inc. (INMD) Misses Q2 EPS by 10c

Integramed America, Inc. (NASDAQ: INMD) reported Q2 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $76.19 million versus the consensus estimate of $76.05 million.

For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
• S&P 500 eyes record as retail slump, Iran risk set up pivotal week